Use with caution in dogs with a history of seizures or neurologic disorders. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Fluralaner is a member of the isoxazoline class. In margin of safety study, kittens and puppies were dosed at three 8-week intervals.īRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. In field studies and safety studies, no dogs or cats experienced serious adverse events. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities. Use caution in cats with a history of neurologic abnormalities. The safety of Bravecto has not been established in breeding, pregnant or lactating cats. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures.īravecto Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Use caution in dogs with a history of seizures. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing.īravecto Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash.

Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. 1-3īravecto has not been shown to be effective for 12 weeks 1 duration in puppies or kittens less than 6 months of age. No problems reported in field trials in dogs and cats that received Bravecto concurrently with other commonly used medication. No known contraindications for Bravecto Chew for Dogs and Bravecto Topical Solution for Dogs and Cats.

Flea and tick pills for dogs